Cannabis sativa sp. as an adjunctive therapy in orofacial pain’s treatment: Narrative review
DOI:
https://doi.org/10.33448/rsd-v12i6.42381Keywords:
Pain; Facial pain; Dentistry; Cannabis; Canabidiol.Abstract
The plant Cannabis sativa sp. is known by its therapeutic potentials at least 5.000 year ago, as says the first humanity’s pharmacopoeia, the Pen-ts’ao ching. However, by the mid 60’s, USA’s neocolonial expansion used its proibition to be able to segregate native peoples (indigenous peoples and africans) who had it as part of their medicine and culture. In parallel with the proibition, evidence-based medicine was in charge of bringing to light results that corroborated the effectiveness of plant’s use in numerous pathologies. Many of these whose conventional treatments were scarce, in addition to being quite associated with side effects and therapeutic resistance. This has made Cannabis increasingly studied and used, including in dental patients, in an attempt to treat orofacial pain symptoms. Such pathology is directly linked to dentistry, encompassing painful conditions in the extra and intraoral region. In view of this, the objective of this work is to search for scientific articles, without time limit, which dealt with the use of formulations containing Cannabis extract in dentistry. Evidences are then presented to justify the possibility of its use by dental professionals, as a possible way to treat orofacial pain unresponsive to existing conventional treatments. The objective of this work is to search for scientific articles obtained from Google Scholar, Scientific Electronic Library (Scielo), PubMed and CAPES journals, without time limit, dealing with the use of formulations containing Cannabis extract in dentistry. Evidences are then presented to justify the possibility of its use by dental professionals, as a possible way to treat orofacial pain unresponsive to existing conventional treatments.
References
Ananthan, S., & Benoliel, R. (2020). Chronic orofacial pain. Journal of Neural Transmission, 127, 575-588.
Araya, E. I., Claudino, R. F., Piovesan, E. J., & Chichorro, J. G. (2020). Trigeminal neuralgia: basic and clinical aspects. Current neuropharmacology, 18(2), 109-119.
Badel, T., Zadravec, D., Bašić Kes, V., Smoljan, M., Kocijan Lovko, S., Zavoreo, I., ... & Anić Milošević, S. (2019). Orofacial pain–diagnostic and therapeutic challenges. Acta Clinica Croatica, 58(Supplement 1), 82-89.
Borsani, E., Majorana, A., Cocchi, M. A., Conti, G., Bonadeo, S., Padovani, A., ... & Rodella, L. F. (2014). Epithelial expression of vanilloid and cannabinoid receptors: a potential role in burning mouth syndrome pathogenesis.
Buffon, A. C. (2017). Efeito do sistema endocanabinoide na ação anti-hiperalgésica da gabapentina em modelo animal de dor neuropática induzida por ligadura parcial do nervo isquiático. Programa de Pós-Graduação em Ciência da Saúde.
Campos, J. L. S., & Schwingel, R. A. (2023). O Uso de canabidiol como estratégia terapêutica para doenças inflamatórias e analgesia na odontologia. Revista Mato-grossense de Odontologia e Saúde, 1(1), 28-38.
Cluny, N. L., Vemuri, V. K., Chambers, A. P., Limebeer, C. L., Bedard, H., Wood, J. T., ... & Sharkey, K. A. (2010). A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents. British journal of pharmacology, 161(3), 629-642.
Conti, P. C. R., Gonçalves, D. A. D. G., Conti, A. C. D. C. F., Cunha, C. O., Rubira, C. M. F., Costa, D. M. F., ... & Costa, Y. M. (2022). Classificação Internacional de Dor Orofacial, primeira edição (ICOP). Headache Medicine, 13(1), 3-97.
DeSantana, J. M., Perissinotti, D. M. N., Oliveira Junior, J. O. D., Correia, L. M. F., Oliveira, C. M. D., & Fonseca, P. R. B. D. (2020). Definição de dor revisada após quatro décadas. BrJP, 3, 197-198.
de Siqueira, J. T. T., & Teixeira, M. J. (2009). Dores orofaciais: diagnóstico e tratamento. Artmed Editora.
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., ... & Mechoulam, R. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258(5090), 1946-1949.
Fein, A. (2009). Nociceptors: the cells that sense pain. Nociceptors.
Ferreira, T. B. S. (2022). O uso da cannabis para o tratamento da dor orofacial: revisão de literatura.
Gajofatto, A. (2016). Refractory trigeminal neuralgia responsive to nabiximols in a patient with multiple sclerosis. Multiple sclerosis and related disorders, 8, 64-65.
Gaoni, Y., & Mechoulam, R. (1964). Isolation, structure, and partial synthesis of an active constituent of hashish. Journal of the American chemical society, 86(8), 1646-1647.
Golanska, P., Saczuk, K., Domarecka, M., Kuć, J., & Lukomska-Szymanska, M. (2021). Temporomandibular Myofascial Pain Syndrome—Aetiology and Biopsychosocial Modulation. A Narrative Review. International Journal of Environmental Research and Public Health, 18(15), 7807.
Hou, J. P. (1977). The development of Chinese herbal medicine and the Pen-ts' ao. The American Journal of Chinese Medicine, 5(02), 117-122.
Li, H. L. (1974). An archaeological and historical account of cannabis in China. Economic botany, 28(4), 437-448.
Maldonado, R., Baños, J. E., & Cabañero, D. (2016). The endocannabinoid system and neuropathic pain. Pain, 157, S23-S32.
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 346(6284), 561-564.
Matsuka, Y. (2022). Orofacial Pain: Molecular Mechanisms, Diagnosis, and Treatment 2021. International Journal of Molecular Sciences, 23(9), 4826.
McDonough, P., McKenna, J. P., McCreary, C., & Downer, E. J. (2014). Neuropathic orofacial pain: cannabinoids as a therapeutic avenue. The international journal of biochemistry & cell biology, 55, 72-78.
Mechtler, L., Hart, P., Bargnes, V., & Saikali, N. (2019). Medical Cannabis Treatment in Patients with Trigeminal Neuralgia (P5. 10-020).
Musto, D. F. (1972). The marihuana tax act of 1937. Archives of General Psychiatry, 26(2), 101-108.
Natalia, G. R. C., & Thanízia, R. V. (2019). Síndrome da boca Ardente. Uniube, 2019/2.
Nitecka-Buchta, A., Nowak-Wachol, A., Wachol, K., Walczyńska-Dragon, K., Olczyk, P., Batoryna, O., ... & Baron, S. (2019). Myorelaxant effect of transdermal cannabidiol application in patients with TMD: a randomized, double-blind trial. Journal of clinical medicine, 8(11), 1886.
Pertwee, R. G., Howlett, A. C., Abood, M. E., Alexander, S. P. H., Di Marzo, V., Elphick, M. R., ... & Ross, R. (2010). International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2. Pharmacological reviews, 62(4), 588-631.
Romero‐Sandoval, E. A., Fincham, J. E., Kolano, A. L., Sharpe, B. N., & Alvarado‐Vázquez, P. A. (2018). Cannabis for chronic pain: challenges and considerations. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 38(6), 651-662.
Rother, E. T. (2007). Revisão sistemática x revisão narrativa. Acta Paul. Enferm, 20(2).
Santos, L. G. A. (2018). Associação entre o bruxismo do sono e DTM muscular: implicações e terapêuticas.
Small, E., & Cronquist, A. (1976). A practical and natural taxonomy for Cannabis. Taxon, 405-435.
Starowicz, K., & Finn, D. P. (2017). Cannabinoids and pain: sites and mechanisms of action. Advances in Pharmacology, 80, 437-475.
Tambeli, C. H., Martins, G. A., Barbosa, S. L., & Machado, T. T. (2023). Abordagem integrativa do uso terapêutico da cannabis nas dores orofaciais. BrJP.
Tanney, C. A., Backer, R., Geitmann, A., & Smith, D. L. (2021). Cannabis glandular trichomes: a cellular metabolite factory. Frontiers in Plant Science, 1923.
Vlăduțu, D., Popescu, S. M., Mercuț, R., Ionescu, M., Scrieciu, M., Glodeanu, A. D., ... & Mercuț, V. (2022). Associations between bruxism, stress, and manifestations of temporomandibular disorder in young students. International Journal of Environmental Research and Public Health, 19(9), 5415.
Wilson, R. I., & Nicoll, R. A. (2002). Endocannabinoid signaling in the brain. science, 296(5568), 678-682.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Estéfane Sobral Campos; Lucas Fonseca Carvalho Silveira; Caian Dourado Souza; Marcela Santos Rodrigues; Valéria Pinto dos Santos; Lucas Alves da Mota Santana; Sara Juliana de Abreu de Vasconcellos
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
